Sequential EGFR-TKI strategy to overcome acquired resistance to afatinib: novel secondary mutations L792F and C797S in addition to T790M
Sequential EGFR-TKI strategy to overcome acquired resistance to afatinib: novel secondary mutations L792F and C797S in addition to T790M
复制标题
序贯 EGFR-TKI 策略克服阿法替尼获得性耐药：除 T790M 外，新的二次突变 L792F 和 C797S
DOI：
--
复制
发表时间：
2016
期刊：
影响因子：
--
通讯作者：
et al.
中科院分区：
文献类型：
--
作者：
Sesumi;Y.;and Mitsudomi;T.;et al.
